Country Trust Bank Has $104,000 Holdings in CVS Health Co. (NYSE:CVS)

Country Trust Bank decreased its stake in CVS Health Co. (NYSE:CVS - Free Report) by 99.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,312 shares of the pharmacy operator's stock after selling 381,027 shares during the quarter. Country Trust Bank's holdings in CVS Health were worth $104,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Mediolanum International Funds Ltd grew its holdings in CVS Health by 75.2% during the fourth quarter. Mediolanum International Funds Ltd now owns 23,111 shares of the pharmacy operator's stock valued at $1,013,000 after purchasing an additional 9,917 shares during the period. SOL Capital Management CO grew its holdings in shares of CVS Health by 12.2% in the 4th quarter. SOL Capital Management CO now owns 79,790 shares of the pharmacy operator's stock valued at $3,582,000 after buying an additional 8,648 shares during the period. Crews Bank & Trust bought a new stake in shares of CVS Health in the 4th quarter valued at $369,000. Swedbank AB raised its stake in CVS Health by 1.2% during the 4th quarter. Swedbank AB now owns 1,405,812 shares of the pharmacy operator's stock worth $63,107,000 after buying an additional 16,923 shares during the period. Finally, Hantz Financial Services Inc. grew its stake in CVS Health by 20.1% in the fourth quarter. Hantz Financial Services Inc. now owns 2,416 shares of the pharmacy operator's stock valued at $108,000 after acquiring an additional 404 shares during the period. Institutional investors own 80.66% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on CVS shares. Truist Financial dropped their price target on CVS Health from $67.00 to $60.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. Royal Bank of Canada cut their price target on shares of CVS Health from $68.00 to $58.00 and set an "outperform" rating on the stock in a research note on Friday, November 15th. StockNews.com downgraded shares of CVS Health from a "hold" rating to a "sell" rating in a research report on Thursday, November 14th. Evercore ISI boosted their price objective on shares of CVS Health from $60.00 to $65.00 and gave the company an "outperform" rating in a research report on Monday. Finally, Deutsche Bank Aktiengesellschaft raised CVS Health from a "hold" rating to a "buy" rating and set a $66.00 price target on the stock in a research note on Tuesday, December 3rd. One analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have issued a buy rating to the company's stock. According to MarketBeat.com, CVS Health presently has an average rating of "Moderate Buy" and a consensus target price of $68.12.

CVS Health Stock Performance

Shares of CVS opened at $56.84 on Friday. The company has a market cap of $71.53 billion, a PE ratio of 14.43, a price-to-earnings-growth ratio of 0.62 and a beta of 0.59. The firm has a 50-day moving average of $51.27 and a 200-day moving average of $56.17. CVS Health Co. has a one year low of $43.56 and a one year high of $80.75. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59.

CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping analysts' consensus estimates of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The firm had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. During the same quarter in the previous year, the business earned $2.21 earnings per share. The business's revenue was up 6.3% compared to the same quarter last year. As a group, equities analysts forecast that CVS Health Co. will post 5.18 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be issued a $0.665 dividend. The ex-dividend date of this dividend is Thursday, January 23rd. This represents a $2.66 annualized dividend and a dividend yield of 4.68%. CVS Health's dividend payout ratio is currently 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.